🔎 Trials Near Me

Home › Osteosarcoma › Minnesota › Minneapolis

Osteosarcoma clinical trials in Minneapolis, MN

3 studies for Osteosarcoma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • University of Minnesota/Masonic Cancer Center, Minneapolis
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

RecruitingPhase 3
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
  • Children's Hospital and Clinics of Minn, Minneapolis
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

Osteosarcoma trials in other cities

Other studies in Minneapolis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.